Risk factors of diabetic retinopathy
DR Pathogenesis
Diabetic retinopathy classification
Scottish DR grading scheme
Diabetic retinopathy signs
Diabetic Maculopathy, M1 and M2 presentation
Treatment of DR
Treatment of Macular oedema
- anti-VEGF injections (some px’s require continuous injections as oedema reoccurs when injections stop)
- laser photocoagulation
- sub threshold diode laser
Retinal Vein Occlusion Risk Factors
Branch Retinal Vein Occlusion Signs
FUNDUS
- Dilation and tortuosity of affected segment
- blot haemorrhages
- cotton wool spots
- retinal neovascularisation (8% risk)
- chronic macular oedema
- pre-retinal and vitreous haemorrhages
- potential RD
Branch Retinal Vein Occlusion Management
BRVO Prognosis
Non Ischemic CRVO signs/symptoms
FUNDUS
- signs present in all quadrants
- tortuosity and dilation
- Cotton wool spots
- dot/blot and flame haemorrhages
- optic disc and macular oedema
- patchy ischemic retinal whitening at posterior pole
Ischemic Central Retinal Vein Occlusion
Hemiretinal Vein occlusion
Hemiretinal vein occlusion signs
FUNDUS (BRVO)
- Dilation and tortuosity of affected segment
- blot haemorrhages
- cotton wool spots
- retinal neovascularisation (8% risk)
- chronic macular oedema
- pre-retinal and vitreous haemorrhages
- potential RD
CRVO treatment
Treatment of macular oedema
- intraretinal anti VEGF agents
- Intravitreal dexamethasome implant
Treatment of neovascularisation
- panretinal photocoagulation (1500-2000 burns spaced a burns width apart, avoiding areas of haemorrhage)
- anti VEGF injections every 6 weeks
- regular check ups to observe if neovascular glaucoma develops
Amaurosis Fugax
Branch Retinal Artery Occlusion signs
Central Retinal Artery Occlusion Signs
Cilioretinal Artery Occlusion
Treatment of Acute Retinal Artery Occlusion
Ocular Ischemic Syndrome
Ocular Ischemic Syndrome Signs
Ocular Ischemic Syndrome management